altretamine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, MR | 1 |
| Bonomi, PD | 1 |
| Pazdur, R | 1 |
| Stolbach, L | 1 |
| Mason, B | 1 |
| Ettinger, D | 1 |
2 other studies available for altretamine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non | 2008 |
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; C | 1986 |